Teladoc Health
TDOC
230 hedge funds and large institutions have $3.11B invested in Teladoc Health in 2018 Q1 according to their latest regulatory filings, with 45 funds opening new positions, 91 increasing their positions, 65 reducing their positions, and 20 closing their positions.
125% more first-time investments, than exits
New positions opened: 45 | Existing positions closed: 20
40% more repeat investments, than reductions
Existing positions increased: 91 | Existing positions reduced: 65
18% more capital invested
Capital invested by funds: $2.64B → $3.11B (+$471M)
12% more funds holding
Funds holding: 205 → 230 (+25)
4% less call options, than puts
Call options by funds: $10.4M | Put options by funds: $10.9M
7.48% less ownership
Funds ownership: 132.48% → 125% (-7.5%)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GTP
Global Thematic Partners
New York
|
+$48.2M |
| 2 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$23.3M |
| 3 |
PA
Perceptive Advisors
New York
|
+$19.6M |
| 4 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
+$17.7M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$16.8M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$29.8M |
| 2 |
BBHC
Brown Brothers Harriman & Co
New York
|
-$26.3M |
| 3 |
CCI
Columbus Circle Investors
|
-$16.7M |
| 4 |
TA
Teachers Advisors
New York
|
-$13.9M |
| 5 |
HRCM
Hood River Capital Management
Palm Beach Gardens,
Florida
|
-$13.9M |
TDOC Hedge Fund Activity: Q1 2018 in Review
230 of the 4,373 institutional investors tracked by Wall St. Rank reported a position in Teladoc Health (TDOC) for Q1 2018, worth a combined $3.11B — up 18% from $2.64B a quarter earlier.
Buyers outnumbered sellers: 45 funds opened new TDOC positions and 20 closed out — a net gain of 25 holders — while 91 added to existing stakes and 65 trimmed.
The largest buyer was Global Thematic Partners, opening a new position worth an estimated $48.2M. The largest seller was T. Rowe Price Associates, cutting an estimated $29.8M.
- 230 institutional investors held Teladoc Health (TDOC) as of Q1 2018, up from 205 in Q4 2017.
- Funds reported $3.11B of Teladoc Health stock for Q1 2018, up 18% quarter-over-quarter.
- 45 funds opened new Teladoc Health positions in Q1 2018 and 20 closed out, a net change of +25 holders.
- The largest Teladoc Health buyer in Q1 2018 was Global Thematic Partners, an estimated $48.2M added.
- The largest Teladoc Health seller in Q1 2018 was T. Rowe Price Associates, an estimated $29.8M sold.
Based on aggregated 13F filings for Q1 2018.